Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Natural sources  





2 Biosynthesis  



2.1  Synthesis of umbelliferone  





2.2  Synthesis of methoxsalen  







3 Risks and side effects  





4 Society and culture  





5 References  














Methoxsalen






العربية
تۆرکجه
Cymraeg
Deutsch
فارسی
Français
Bahasa Indonesia
Italiano
Српски / srpski
Srpskohrvatski / српскохрватски
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Methoxsalen
Clinical data
Trade namesOxsoralen, Uvadex, 8-mop, others
Other namesxanthotoxin
AHFS/Drugs.comConsumer Drug Information
License data
Pregnancy
category
  • Routes of
    administration
    Extracorporeal, By mouth
    ATC code
    Legal status
    Legal status
  • US: WARNING[3]Rx-only[4][5]
  • Pharmacokinetic data
    Elimination half-life~2 hours
    Identifiers
    • 9-methoxy-7H-furo[3,2-g]chromen-7-one

    CAS Number
    PubChem CID
    DrugBank
    ChemSpider
    UNII
    KEGG
    ChEBI
    ChEMBL
    NIAID ChemDB
    CompTox Dashboard (EPA)
    ECHA InfoCard100.005.516 Edit this at Wikidata
    Chemical and physical data
    FormulaC12H8O4
    Molar mass216.192 g·mol−1
    3D model (JSmol)
    • COc1c2c(ccc(=O)o2)cc3c1occ3

    • InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3 checkY

    • Key:QXKHYNVANLEOEG-UHFFFAOYSA-N checkY

      (verify)

    Methoxsalen (orxanthotoxin) sold under the brand name Oxsoralen among others, is a medication used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to ultraviolet (UVA) light from lamps or sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. Levels of individual patient PUVA exposure were originally determined using the Fitzpatrick scale. The scale was developed after patients demonstrated symptoms of phototoxicity after oral ingestion of methoxsalen followed by PUVA therapy. Chemically, methoxsalen belongs to a class of organic natural molecules known as furanocoumarins. They consist of coumarin annulated with furan. It can also be injected and used topically.

    Natural sources[edit]

    In 1947, methoxsalen was isolated (under the name "ammoidin") from the plant Ammi majus, bishop's weed.[6][7]

    In 1970, Nielsen extracted 8-methoxypsoralen from four species of the genus Heracleum in the carrot family Apiaceae,[8][9] including Heracleum mantegazzianum and Heracleum sphondylium. An additional 32 species of the genus Heracleum were found to contain 5-methoxypsoralen (bergapten) or other furanocoumarins.

    Biosynthesis[edit]

    The biosynthetic pathway is a combination of the shikimate pathway, which produces umbelliferone, and the mevalonate pathway.

    Synthesis of umbelliferone[edit]

    Umbelliferone

    Umbelliferone is a phenylpropanoid and as such is synthesized from L-phenylalanine, which in turn is produced via the shikimate pathway. Phenylalanine is lysated into cinnamic acid, followed by hydroxylationbycinnamate 4-hydroxylase to yield 4-coumaric acid. The 4-coumaric acid is again hydroxylated by cinnamate/coumarate 2-hydroxylase to yield 2,4-dihydroxy-cinnamic acid (umbellic acid) followed by a bond rotation of the unsaturated bond adjacent to the carboxylic acid group. Finally an intramolecular attack from the hydroxyl group of C2' to the carboxylic acid group closes the ring and forms the lactone umbelliferone.

    Synthesis of methoxsalen[edit]

    Dimethylallyl pyrophosphate

    The biosynthetic route then continues with the activation of dimethylallyl pyrophosphate (DMAPP), produced via the mevalonate pathway, to form a carbo-cation via the cleavage of the diphosphates. Once activated, the enzyme umbelliferone 6-prenyltransferase catalyzes a C-alkylation between DMAPP and umbelliferone at the activated position ortho to the phenol, yielding demethylsuberosin. This is then followed by a hydroxylation catalyzed by the enzyme marmesin synthase to yield marmesin. Another hydroxylation is catalyzed by psoralen synthase to yield psoralen. A third hydroxylation by the enzyme psoralen 8-monooxygenase yields xanthotoxol which is followed by a methylation via the enzyme xanthotoxol O-methyltransferase and S-adenosyl methionine to yield methoxsalen.[10]

    Risks and side effects[edit]

    Patients with high blood pressure or a history of liver problems are at risk for inflammation and irreparable damage to both liver and skin. The eyes must be protected from UVA radiation. Side effects include nausea, headaches, dizziness, and in rare cases insomnia.

    Methoxsalen has also been classified as an IARC Group 1 carcinogen (known to cause cancer) but is only cancerous when combined with light - UVA radiation.[11]

    Society and culture[edit]

    Author John Howard Griffin (1920–1980) used the chemical to darken his skin in order to investigate racial segregation in the American South. He wrote the book Black Like Me (1961) about his experiences.[12]

    References[edit]

    1. ^ a b "Uvadex". Therapeutic Goods Administration (TGA). 13 December 2019. Retrieved 25 August 2020.
  • ^ a b "AusPAR: Methoxsalen". Therapeutic Goods Administration (TGA). 12 December 2019. Retrieved 17 September 2021.
  • ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
  • ^ "Uvadex- methoxsalen injection, solution". DailyMed. U.S. National Library of Medicine. Retrieved 17 September 2021.
  • ^ "Oxsoralen-Ultra- methoxsalen capsule, liquid filled". DailyMed. U.S. National Library of Medicine. Retrieved 17 September 2021.
  • ^ Fahmy IR, Abu-Shady H (1947). "Ammi majus Linn.; pharmacognostical study and isolation of a crystalline constituent, ammoidin". Quarterly Journal of Pharmacy and Pharmacology. 20 (3): 281–91, discussion 426. PMID 20273299.
  • ^ Marshall SR (June 2006). "Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?". Nature Clinical Practice. Oncology. 3 (6). Nature Publishing: 302–314. doi:10.1038/ncponc0511. PMID 16757968. S2CID 8441159.
  • ^ Nielsen BE (1970). Coumarins of Umbelliferous plants. Copenhagen: Royal Danish School of Pharmacy. Cited by Mitchell and Rook (1979).
  • ^ Mitchell J, Rook A (1979). Botanical Dermatology: Plants and Plant Products Injurious to the Skin. Vancouver: Greengrass. pp. 692–699. ISBN 978-0-88978-047-7.
  • ^ Dewick PM (2009). Medicinal Natural Products: A Biosynthetic Approach (3rd ed.). John Wiley & Sons. pp. 161, 164–165.
  • ^ "Known and Probable Human Carcinogens". American Cancer Society. Archived from the original on 30 September 2016.
  • ^ Mikkelson D (27 July 2003). "Death of John Howard Griffin". snopes.com. Snopes Media Group Inc.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Methoxsalen&oldid=1213639887"

    Categories: 
    CYP1A2 inhibitors
    CYP3A4 inhibitors
    Photosensitizing agents
    IARC Group 1 carcinogens
    Furanocoumarins
    O-methylated coumarins
    Catechol ethers
    General cytochrome P450 inhibitors
    Orphan drugs
    Plant toxins
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    ECHA InfoCard ID from Wikidata
     



    This page was last edited on 14 March 2024, at 07:15 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki